NEJM (@NEJM) header
NEJM (@NEJM) profile picture

The New England Journal of Medicine is the world’s leading medical journal and website.

Boston, MA
Joined March 2009
Photo by NEJM (@NEJM)Photo by NEJM (@NEJM)Photo by NEJM (@NEJM)Photo by NEJM (@NEJM)Photo by NEJM (@NEJM)Photo by NEJM (@NEJM)Photo by NEJM (@NEJM)Photo by NEJM (@NEJM)Photo by NEJM (@NEJM)Photo by NEJM (@NEJM)
Pinned Tweet
𝘏. 𝘱𝘺𝘭𝘰𝘳𝘪 infection is an infectious disease, and treatment regimens should ideally be guided by antimicrobial-susceptibility testing whenever possible. 🔗 nej.md/4Bj3O58 Both phenotypic (culture-based) and molecular methods of antimicrobial-susceptibility testing are available (seen in figure). Culture-based testing remains the reference standard because it is the only method that can ascertain the susceptibility of isolates to all antibiotics commonly used for eradication. Molecular antimicrobial-susceptibility testing offers greater efficiency than culture-based testing by eliminating the need for 𝘏. 𝘱𝘺𝘭𝘰𝘳𝘪 culture. Molecular-based testing can be conducted with fresh or formalin-fixed gastric-tissue samples (used for histopathological examination) and successfully cultured isolates. More recently, gastric-fluid samples obtained from a swallowed gastric string have emerged as a cost-effective alternative culture-based testing method. Stool-based molecular antimicrobial-susceptibility testing is now available, which avoids invasive endoscopy. Commercial polymerase-chain-reaction–based kits are now available for identifying 𝘏. 𝘱𝘺𝘭𝘰𝘳𝘪 resistance to clarithromycin and levofloxacin by detecting specific mutations in the 𝘏. 𝘱𝘺𝘭𝘰𝘳𝘪 23S ribosomal RNA and gyrA genes, respectively. A meta-analysis reported high accuracy of these molecular methods for detecting antibiotic resistance in gastric-biopsy samples, with sensitivity and specificity of 96% and 96%, respectively, for clarithromycin resistance and 97% and 99% for quinolone resistance. Learn more in the Review Article “𝘏𝘦𝘭𝘪𝘤𝘰𝘣𝘢𝘤𝘵𝘦𝘳 𝘱𝘺𝘭𝘰𝘳𝘪 Infection — Advances, Challenges, and the Road Ahead” by Hong Li, MD, PhD, Francis Megraud, MD, and Barry J. Marshall, MD: nej.md/4Bj3O58
8
175
2
592
43,557
An interim analysis of a phase 3 randomized trial involving adults with IgA nephropathy showed that ravulizumab, a terminal complement inhibitor, led to a significantly greater reduction in proteinuria than placebo. Full I CAN trial results and Research Summary: nej.md/4iwTFdS
2
1
1,112
Perspective by Divya Mallampati, MD, MPH, Chase Binion, PhD, and Neeta L. Vora, MD: Equity in Maternal–Fetal Medicine — Technological Advances and a Potential Path Forward nej.md/4AjlYCz #MedicalEthics #MedicalPractice
1
1
1
1
2,453
NEJM retweeted
In the latest episode of the AI Grand Rounds podcast, @munjalshah, co-founder and CEO of @hippocraticai, believes voice-based clinical agents may help health systems reach patients who otherwise fall through the cracks. Listen to the full episode nejm.ai/ep48
2
5
6
2,275
Images in Clinical Medicine: Lung Hernia with a Chest-Wall Bulge nej.md/4iGMi2l #Surgery #Pulmonology
2
8
4,374
Subacute sclerosing panencephalitis (SSPE), a progressive neurodegenerative disorder that eventually leads to death, can occur years after measles infection. @NEJMClinician Editor-in-Chief @PaulSaxMD explains why physicians should mention the devastating effects of SSPE when counseling parents about vaccination. See what else matters this week at clinician.nejm.org.
5
14
4
47
9,906
Looking closely at your patients can uncover information they haven’t yet, or can’t, put into words, writes @MKittlesonMD in a new NEJM Voices blog post. Read the post and sign up for email alerts: nej.md/3XaplgU
4
1
13
6,989
A new review examines current tools and recent advancements in malaria control and prevention. Read the full review: nej.md/4sQ0qLg
1
7
24
8,834
NEJM retweeted
The authors analyze the degree to which clinical specialties are shielded from, or threatened by, AI depending on how much of their work requires in-person physical interaction. Learn more: nejm.ai/3UDkrIv
166
422
268
1,285
971,402
Patients arrive carrying information they haven’t yet, or can’t, put into words. Before the history, before the exam, before the first question, look carefully. The story is already in the room. The Power of Observation voices.nejm.org/doi/full/10.… @NEJM
3
10
1
33
5,833
Among patients with acute coronary syndromes undergoing percutaneous coronary intervention, the risk of ischemic events was not lower with a default prasugrel policy than with a default ticagrelor policy. Full SWITCH-SWEDEHEART trial results and Research Summary: nej.md/4wGVCZd #ESCCongress
3
29
97
14,043
How should clinicians respond when parents express fears related to vaccinating their children? 2025–26 NEJM Editorial Fellow Katerina Lin, MD, shares practical approaches to childhood vaccine hesitancy. Go deeper on this subject: nej.md/3Riw19N
5
21
3
63
11,593
Original Article: Semaglutide for the Treatment of Obesity in Children 6 to <12 Years of Age (phase 3 STEP Young trial) nej.md/4ArUURG #ObesityWeek #OW2026 | @ObesityWeek
7
28
2
98
18,322
Images in Clinical Medicine: Lung Hernia with a Chest-Wall Hematoma nej.md/4k9ru6a #EmergencyMedicine #Radiology
1
6
1
21
12,036
Perspective by Nicholas Peoples, MD, Katherine Hoops, MD, JD, MPH, and Eric W. Fleegler, MD, MPH: Mass Surveillance with Artificial Intelligence — A New Determinant of Health? nej.md/4k39Als #AIinMedicine #PublicHealth
2
4
14
9,643
Original Article: Ravulizumab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial (I CAN trial) nej.md/4iwTFdS #Nephrology
15
1
63
12,181
𝐍𝐨𝐰 𝐚𝐯𝐚𝐢𝐥𝐚𝐛𝐥𝐞 𝐢𝐧 𝑵𝑬𝑱𝑴 𝑬𝒗𝒊𝒅𝒆𝒏𝒄𝒆! A new Public Health Alerts report, published in partnership with @CIDRAP: Outcomes among Pregnant Women with Measles and Their Infants in the United States — Preliminary Analysis, 2025–2026 eviden.cc/4zOqTvv
4
3
9
5,448
Correspondence: Interferon-γ Underlying Thymoma-Associated Immune Dysregulation nej.md/3UuLcil #Immunology
1
6
19
8,219
In a new NEJM Voices blog post, Don Dizon, MD, shares how cancer reshapes intimate relationships, challenging couples to find new ways to connect. Read “Sex, Intimacy, Cancer, and Couples” and sign up for email alerts: nej.md/48TiGua
3
10
7,084
A trial of venous thromboembolism (VTE) prophylaxis after hip or knee arthroplasty did not show that aspirin was noninferior to rivaroxaban or warfarin for symptomatic VTE or death. Warfarin and rivaroxaban were not noninferior to aspirin for safety. Full PEPPER trial results and Research Summary: nej.md/4iIxVL0
6
58
6
227
33,312
Presented at #ObesityWeek: In a phase 3, double-blind, randomized trial involving 167 children (6 to <12 years of age) with obesity, treatment with semaglutide resulted in a significantly greater reduction in BMI than placebo. Full STEP Young trial results: nej.md/4ArUURG #OW2026 | @ObesityWeek
13
28
4
88
17,880